Bausch Health Companies to Present at Cowen Annual Health Care Conference

LAVAL, QC / ACCESSWIRE / March 1, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that members of company management will participate at the Cowen Annual Health Care Conference in Boston on March 5, 2024. The Bausch Health team will be hosting a fireside chat at 12:50 p.m. EST, and a live webcast will be accessible through the Investor Relations section of the Bausch Health website at https://ir.bauschhealth.com/. A replay of the webcast will be posted after the presentation and will be available for a limited time following the event.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

Investor Contact:
Solebury Strategic Communications
ir@bauschhealth.com
(877) 281-6642 (toll free)

Media Contact:
Kevin Wiggins
corporate.communications@bauschhealth.com
(908) 541-3785

SOURCE: Bausch Health Companies Inc.

View the original press release on accesswire.com

Staff

Recent Posts

U.S. Ambulatory EHR Market Report 2024-2031 – Integration of AI and ML Technologies to Offer Growth Opportunities for Market Players – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Ambulatory EHR Market Size, Share, Forecast, & Trends Analysis by Deployment Mode,…

34 minutes ago

IMPLANET Announces Its 2025 Financial Calendar

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity…

3 hours ago

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

3 hours ago

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

4 hours ago

VIV™ Ring: The World’s 1st Smart Ring with Generative Sleep Aid Sound at CES 2025

The Intuitive Smart Ring Challenging Oura and Galaxy RingGenerative Sleep Aid Sound Enhancing Beyond Biometrics…

4 hours ago

FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions

SILVER SPRING, Md., Jan. 6, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration…

4 hours ago